The Bifidogenic Effect of 2'Fucosyllactose Is Driven by Age-Specific <i>Bifidobacterium</i> Species, Demonstrating Age as an Important Factor for Gut Microbiome Targeted Precision Medicine.

It was hypothesized that the increase in Bifidobacteriaceae for the infant group failed to reach significance due to large interpersonal differences that obscured the statistical results and because the communities within this age group were already predominantly Bifidobacterium (four of six subjects), and these subjects were already consuming HMOs in their diet.

also in 4,113 other papers